BECTON, DICKINSON AND COMPANY

(BDX)
  Report
Real-time Estimate Cboe BZX  -  03:08 2022-07-05 pm EDT
247.37 USD   -1.76%
09:54aEvercore ISI Adjusts Price Target on Becton Dickinson and Co. to $265 From $300, Keeps Outperform Rating
MT
06:56aBD Issues 2021 ESG Report
PR
06/30Becton, Dickinson Unveils Combination Assay for COVID-19, Other Respiratory Viruses
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $255 From $265, Maintains Neutral Rating

05/06/2022 | 05:45am EDT


© MT Newswires 2022
All news about BECTON, DICKINSON AND COMPANY
09:54aEvercore ISI Adjusts Price Target on Becton Dickinson and Co. to $265 From $300, Keeps ..
MT
06:56aBD Issues 2021 ESG Report
PR
06/30Becton, Dickinson Unveils Combination Assay for COVID-19, Other Respiratory Viruses
MT
06/30BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Viru..
PR
06/30Becton, Dickinson and Company Launches Combination Test for COVID-19, Influenza A/B and..
CI
06/29BD - Harris Poll Survey Reveals Clinicians Continue to See COVID-19 Testing as Critical
AQ
06/24Wells Fargo Upgrades Becton Dickinson and Co. to Overweight From Equalweight; Price Tar..
MT
06/23Becton, Dickinson and Company Recalls Intraosseous Products
MT
06/22BD Voluntarily Recalling Intraosseous Products
DJ
06/22BD Announces Voluntary Recall on Intraosseous Products
CI
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2022 18 678 M - -
Net income 2022 1 770 M - -
Net Debt 2022 13 463 M - -
P/E ratio 2022 38,7x
Yield 2022 1,51%
Capitalization 71 779 M 71 779 M -
EV / Sales 2022 4,56x
EV / Sales 2023 4,31x
Nbr of Employees 75 000
Free-Float 77,5%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 251,80 $
Average target price 280,50 $
Spread / Average Target 11,4%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Christopher J. DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY2.45%71 779
ABBOTT LABORATORIES-21.69%192 989
MEDTRONIC PLC-11.67%121 417
BAXTER INTERNATIONAL INC.-23.71%32 976
HOYA CORPORATION-31.01%31 454
DEXCOM, INC.-42.17%30 470